Union Health Minister Mansukh Mandaviya on Thursday said he has held a meeting with Dr Reddy's Laboratories Chairman Satish Reddy regarding the production and supply of COVID-19 vaccine Sputnik V.......
Drug major Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet. IMAGE:......
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has......
Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said......
"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr......
In the cataclysmic fall by techs led by Infosys, the sudden downturn by Dr Reddy's Labs late Friday went virtually innoticed. But market rumours suggested that the company is having to contend with......
Dr Reddy's Labs gave the market reason to devalue the scrip further after it announced that it was dropping three compounds from its research pipeline. No sooner trading commenced Thursday, the......
Markets ended higher on Thursday after Dr Reddy's Labs strategic tie-up with Amgen fuelled a rally in pharma shares while capital goods shares firmed up on renewed buying interest. India which......
India's generic drug manufacturer, Dr Reddy's Laboratories, suffered a setback when a US' Court of Appeals ruled that it infringed on Pfizer Pharmaceutical company's patent for the blood pressure......
Dr Reddy's shrugged off recent volatility on Wednesday and moved tenaciously on filing new gernerics with the US FDA. The scrip of the domestic pharma major nudged up 0.6% to Rs 905.65 on BSE in......